CLASS II Device recall · Reported 3 Jun 2020 · FDA Enforcement Report

Optilite Rheumatoid Factor Kit recalled by The Binding Site Group

The Binding Site Group is recalling Optilite Rheumatoid Factor Kit, distributed in 20 states. The recall was initiated on 7 Oct 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesKit Lot Number: 428224
Quantity recalled478 kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2110-2020
FDA event ID
85366
Recalling firm
The Binding Site Group, Birmingham, N/A
Classification
Class II
Status
Terminated
Recall initiated
7 Oct 2019
FDA classified
22 May 2020
Reported
3 Jun 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

7 Oct 2019Recall initiated by company
22 May 2020Classified by FDA+228 days
3 Jun 2020Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Assigned Rheumatoid Factor (RF) calibrator value for calibrator component included in kit used to aid in the diagnosis of rheumatoid arthritis over recovers by 7% in comparison to the reference material RF serum. This could result in reporting abnormal (false positive) results, which may lead to unnecessary additional serological testing and a delay in treatment.

Product as listed by the FDA

Optilite Optilite Rheumatoid Factor Kit, Ref: LK151.OPT.A, IVD, Rx Only, UDI: 05051700020015 (kit ea. containing four components)

Where it was distributed

US: AL, AR, AZ, FL, GA, KY, MA, MD, MI, MN, MS, NC, NE, NY, OR, PA, TX, VT, WA, WI OUS: None

AlabamaArkansasArizonaFloridaGeorgiaKentuckyMassachusettsMarylandMichiganMinnesotaMississippiNorth CarolinaNebraskaNew YorkOregonPennsylvaniaTexasVermontWashingtonWisconsin

Questions about this recall

Why was it recalled?

Assigned Rheumatoid Factor (RF) calibrator value for calibrator component included in kit used to aid in the diagnosis of rheumatoid arthritis over recovers by 7% in comparison to the reference material RF serum. This could result in reporting abnormal (false positive) results, which may lead to unnecessary additional serological testing and a delay in treatment.

Which lots are affected?

Kit Lot Number: 428224

Where was it sold?

US: AL, AR, AZ, FL, GA, KY, MA, MD, MI, MN, MS, NC, NE, NY, OR, PA, TX, VT, WA, WI OUS: None

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from The Binding Site Group

All 29

Other Other Medical Devices recalls

All 13,857